Association of IL-10, IL-4, and IL-28B gene polymorphisms with spontaneous clearance of hepatitis C virus in a population from Rio de Janeiro

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Ramos, Juliene Antonio ^a,b   Silva, Rosane ^a,d   Hoffmann, Luísa ^a   Ramos, Ana Lucia Araújo ^a   Cabello, Pedro Hernan ^c   Ürményi, Turán Péter ^a   Villella Nogueira, Cristiane Alves ^a   Lewis Ximenez, Lia ^c   Rondinelli, Edson ^a,d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO FEDERAL DE EDUCAÇÃO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Fellow of the National Research Council   (Brazil)

Author keywords

Acute hepatitis C; Chronic hepatitis C; Cytokines; Gene polymorphism; HCV; Spontaneous viral clearance

Indexed keywords

HEPATITIS C VIRUS;

IL28B PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN DERIVATIVE;

ADULT; AGED; ARTICLE; BRAZIL; FEMALE; GENETIC POLYMORPHISM; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; REMISSION; VIROLOGY;

ADULT; AGED; BRAZIL; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REMISSION, SPONTANEOUS;

EID: 84866156904     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-508     Document Type: Article

References (32)

1. Natural history of chronic hepatitis C. Seeff LB, Hepatology 2002 36 suppl 1 35 S46 12407575
2. Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin. Barrett S, Ryan E, Crowe J, J Hepatol 1999 30 979 983 10.1016/S0168-8278(99)80249-9 10406173
3. Tumor necrosis factor alpha promoter polymorphism at position 238 is associated with chronic active hepatitis C infection. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenfelde KH, Rittner C, J Med Virol 1998 54 173 177 10.1002/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2 9515764
4. Host genetic factors influence disease progression in chronic hepatitis C. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, Purdie DM, Jonsson JR, Hepatology 2000 31 828 833 10.1053/he.2000.6253 10733535
5. Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Tsutsumi T, Suzuki T, Shimoike T, Suzuki R, Moriya K, Shintani Y, Fujie H, Matsuura Y, Koike K, Miyamura T, Hepatology 2002 35 937 946 10.1053/jhep.2002.32470 11915042
6. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM, Hepatology 1996 24 6 9 10.1002/hep.510240102 8707283
7. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. Quiroga JA, Martin J, Pardo M, Carreno V, Dig Dis Sci 1994 39 2485 2496 10.1007/BF02087671 7956620
8. Promoter polymorphism of IL-10 and severity of multiple sclerosis. Luomala M, Lehtimaki T, Huhtala H, Ukkonen M, Koivula T, Hurme M, Elovaara I, Acta Neurol Scand 2003 108 396 400 10.1034/j.1600-0404.2003.00165.x 14616291
9. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Shin HD, Winkler C, Stephens JC, Bream J, Young H, Goedert JJ, OBrien TR, Vlahov D, Buchbinder S, Giorgi J, et al. Proc Natl Acad Sci USA 2000 97 14467 14472 10.1073/pnas.97.26.14467 11121048
10. Interleukin-10 and related cytokines and receptors. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB, Annu Rev Immunol 2004 22 929 979 10.1146/annurev.immunol.22.012703.104622 15032600
11. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV, Eur J Immunogenet 1999 26 1 3 10.1046/j.1365-2370.1999. 00122.x 10068907
12. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Nelson DR, Lauwers GY, Lau JY, Davis GL, Gastroenterology 2000 118 655 660 10.1016/S0016-5085(00)70134- X 10734016
13. IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection. Lio D, Caruso C, Di Stefano R, Colonna Romano G, Ferraro D, Scola L, Crivello A, Licata A, Valenza LM, Candore G, et al. Hum Immunol 2003 64 674 680 10.1016/S0198-8859(03)00080-6 12826369
14. Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma. Gajewski TF, Joyce J, Fitch FW, J Immunol 1989 143 15 22 2525146
15. Estimating the net contribution of interleukin-28B variant to spontaneous hepatitis C virus clearance. di Iulio J, Ciuffi A, Fitzmaurice K, Kelleher D, Rotger M, Fellay J, Martinez R, Pulit S, Furrer H, Günthard HF, et al. Hepatology 2011 531 1446 1454
16. Genome-wide association of IL-28B with response to pegylated interferon-α and ribavirina therapy for chronic hepatitis C. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, et al. Nat Genet 2009 1 5
17. IL-13 receptors and signaling pathways: an evolving web. Hershey GK, J Allergy Clin Immunol 2003 111 677 690 10.1067/mai.2003.1333 12704343
18. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW, Hepatology 1996 24 759 765 10.1002/hep.510240402 8855173
19. Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation. Dharancy S, Podevin P, Aoudjehane L, Batteux F, Rosenberg AR, Soubrane O, Calmus Y, Conti F, Transplantation 2007 83 906 911 10.1097/01.tp.0000258729.68871.be 17460561
20. Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Chen TY, Hsieh YS, Wu TT, Yang SF, Wu CJ, Tsay GJ, Chiou HL, Transl Res 2007 150 116 121 10.1016/j.trsl.2007.01.007 17656331
21. An investigation of polymorphism in the interleukin-10 gene promoter. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV, Eur J Immunogenet 1997 24 1 8 10.1111/j.1365-2370.1997.tb00001.x 9135685
22. Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection. Pereira FA, da Silva NN P, Rodart IF, Carmo TM, Lemaire DC, Reis MG, J Med Virol 2008 80 58 64 10.1002/jmv.21011 18041006
23. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation. Ben-Ari Z, Pappo O, Druzd T, Sulkes J, Klein T, Samra Z, Gadba R, Tambur AR, Tur-Kaspa R, Mor E, Cytokine 2004 27 7 14 10.1016/j.cyto.2004.03.009 15207246
24. Tivation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, Urdea MS, Kolberg JA, Lau JY, Dig Dis Sci 1997 42 2487 10.1023/A:1018804426724 9440625
25. IL-28B is association with response to chronic hepatitis C interferon-alpha and ribavirina therapy. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, et al. Nat Genet 2009 10 1100 1104
26. Genetic variation in IL-28B predicts hepatitis C treatment induced viral clearance. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, et al. Nature 2009 461 399 401 10.1038/nature08309 19684573
27. lambda-Interferons and the single nucleotide polymorphisms: a milestone to tailor-made therapy for chronic hepatitis C. Tanaka Y, Nishida N, Sugiyama M, Tokunaga K, Mizokami M, Hepatol Res 2010 40 449 460 10.1111/j.1872-034X.2010. 00671.x 20546329
28. IL28B: a new wager in the skyline of hepatitis C virus infection. Mangia A, Dig Liver Dis 2010 43 177 179
29. Screening for IL28B gene variants identifies predictors of hepatitis C therapy success. Doehring A, Hofmann WP, Schlecker C, Zeuzem S, Susser S, Geisslinger G, Sarrazin C, Lotsch J, Antivir Ther 2010 15 1099 1106 10.3851/IMP1689 21149916
30. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, et al. Gastroenterolgy 2010 138 1338 1345 10.1053/j.gastro.2009.12. 056
31. Prospective follow-up of patients with acute hepatitis C virus infection in Brazil. Lewis-Ximenez LL, Lauer GM, Schulze Zur Wiesch J, De Sousa PS, Ginuino CF, Paranhos-Baccalá G, Ulmer H, Pfeiffer KP, Goebel G, Pereira JL, Oliveira de Mendes J, et al. Clin Infect Dis 2010 50 1222 1230 10.1086/651599 20235831
32. A simple salting out procedure for extracting DNA from human nucleated cells. Miller SA, Dykes DD, Polesky HF, Nucleic Acids Res 1998 16 1215